CZ20021083A3 - Farmaceutický prostředek - Google Patents

Farmaceutický prostředek Download PDF

Info

Publication number
CZ20021083A3
CZ20021083A3 CZ20021083A CZ20021083A CZ20021083A3 CZ 20021083 A3 CZ20021083 A3 CZ 20021083A3 CZ 20021083 A CZ20021083 A CZ 20021083A CZ 20021083 A CZ20021083 A CZ 20021083A CZ 20021083 A3 CZ20021083 A3 CZ 20021083A3
Authority
CZ
Czechia
Prior art keywords
pharmaceutical composition
component
polysorbate
polyethylene glycols
mixture
Prior art date
Application number
CZ20021083A
Other languages
Czech (cs)
English (en)
Inventor
Joseph Kyuwung Yoon
Richard William Saunders
Mahdi Bakir Fawzi
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of CZ20021083A3 publication Critical patent/CZ20021083A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ20021083A 1999-09-27 2000-09-26 Farmaceutický prostředek CZ20021083A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40577299A 1999-09-27 1999-09-27

Publications (1)

Publication Number Publication Date
CZ20021083A3 true CZ20021083A3 (cs) 2002-06-12

Family

ID=23605168

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20021083A CZ20021083A3 (cs) 1999-09-27 2000-09-26 Farmaceutický prostředek

Country Status (18)

Country Link
EP (1) EP1216033A1 (ko)
JP (1) JP2003510269A (ko)
KR (1) KR20020039354A (ko)
CN (1) CN1391466A (ko)
AR (1) AR025780A1 (ko)
AU (1) AU7615000A (ko)
BR (1) BR0014351A (ko)
CA (1) CA2388474A1 (ko)
CZ (1) CZ20021083A3 (ko)
EA (1) EA200200414A1 (ko)
HK (1) HK1045109A1 (ko)
HU (1) HUP0202972A3 (ko)
IL (1) IL148541A0 (ko)
MX (1) MXPA02003189A (ko)
NO (1) NO20021475L (ko)
PL (1) PL354282A1 (ko)
WO (1) WO2001022945A1 (ko)
ZA (1) ZA200203312B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JP4632288B2 (ja) * 2002-02-27 2011-02-16 塩野義製薬株式会社 難水溶性薬物の吸収性を改善した固形状製剤
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US6287594B1 (en) * 1998-01-20 2001-09-11 Edward S. Wilson Oral liquid compositions

Also Published As

Publication number Publication date
HUP0202972A3 (en) 2003-07-28
HK1045109A1 (zh) 2002-11-15
EP1216033A1 (en) 2002-06-26
ZA200203312B (en) 2003-12-31
IL148541A0 (en) 2002-09-12
NO20021475L (no) 2002-04-16
PL354282A1 (en) 2003-12-29
KR20020039354A (ko) 2002-05-25
NO20021475D0 (no) 2002-03-25
HUP0202972A2 (hu) 2002-12-28
AU7615000A (en) 2001-04-30
MXPA02003189A (es) 2002-09-30
EA200200414A1 (ru) 2002-12-26
AR025780A1 (es) 2002-12-11
CA2388474A1 (en) 2001-04-05
CN1391466A (zh) 2003-01-15
WO2001022945A1 (en) 2001-04-05
JP2003510269A (ja) 2003-03-18
BR0014351A (pt) 2002-06-11

Similar Documents

Publication Publication Date Title
TWI490216B (zh) 用作ｃ型肝炎病毒蛋白酶抑制劑之醫藥組合物
US6437006B1 (en) Pharmaceutical carrier formulation
JPH10511959A (ja) フェノフィブレートおよびポリグリコール化グリセリドを含有する薬学的組成物
AU5114400A (en) Antifungal oral composition containing itraconazole and process for preparing same
PL190420B1 (pl) Twarda kapsułka żelatynowa zawierajaca kompozycjęfarmaceutyczną
US6221391B1 (en) Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
JPH11512115A (ja) 経口投与用製剤組成物
JP2002537242A5 (ko)
JPH09501150A (ja) カプセル製剤
JP5750278B2 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
SK283216B6 (sk) Prípravok obsahujúci cyklosporín a spôsob jeho prípravy
WO2008058234A2 (en) Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility
US6352718B1 (en) Vasopressin antagonist formulation and process
CZ20021083A3 (cs) Farmaceutický prostředek
KR20020064289A (ko) 약제학적 담체 제형
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
WO2004062692A1 (en) Formulation of poorly water-soluble active substances
EP3510997B1 (en) Soft gelatin capsules comprising a suspension of tadalafil
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
KR20010078703A (ko) 신규 제약 제제
SK11352003A3 (sk) Farmaceutický prostriedok
EP1435233A1 (en) Cyclosporin-based pharmaceutical compositions
WO2014010008A1 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
AU2004270069A1 (en) Oral Itraconazole Composition Which is Not Affected by Ingested Food and Process for Preparing Same
MXPA06005247A (es) Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida